Related Experiment Video
Updated: Jun 20, 2025

Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
Exploring pathological link between antimicrobial and amyloid peptides
Yijing Tang1, Yanxian Zhang2, Dong Zhang3
1Department of Chemical, Biomolecular, and Corrosion Engineering, The University of Akron, Ohio 44325, USA. zhengj@uakron.edu.
Amyloid peptides (AMYs) and antimicrobial peptides (AMPs) share structural traits, enabling cross-talk in neurodegenerative diseases and infections. Understanding this interplay may yield novel therapies for both conditions.
Area of Science:
- Biochemistry
- Molecular Biology
- Pathology
Background:
- Amyloid peptides (AMYs) and antimicrobial peptides (AMPs) are distinct peptide families.
- Emerging evidence links AMYs and AMPs in neurodegenerative diseases and microbial infections.
- Shared structural and functional characteristics exist between AMYs and AMPs.
Purpose of the Study:
- To review recent developments in the interplay between AMYs and AMPs.
- To examine the pathological implications of AMY-AMP interactions in disease.
- To highlight challenges and inspire future research in this field.
Main Methods:
- Literature review of existing studies on AMY-AMP interactions.
- Analysis of shared structural and functional properties.
- Discussion of cross-seeding phenomena and bidirectional communication.
Main Results:
- AMYs can exhibit antimicrobial activity, and AMPs can display amyloidogenic properties.
- Cross-seeding between AMYs and AMPs is a key factor in disease pathogenesis.
- The interplay influences both neurodegeneration and host defense mechanisms.
Conclusions:
- The molecular crosstalk between AMYs and AMPs is crucial in infectious and neurodegenerative diseases.
- Further research is needed to fully understand these interactions.
- This knowledge can lead to innovative therapeutic strategies for multiple disorders.
More Related Videos
04:41Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...